Latest News & Features
Americas
Law firm Lerner David Littenberg Krumholz & Mentlik has hired Tedd Van Buskirk as partner in its intellectual property practice in Westfield, New Jersey. 26 January 2016
Africa
Pharmaceutical companies including Cipla and Natco Pharma have signed a sub-licensing deal enabling them to produce a generic version of Bristol Myers Squibb’s hepatitis C drug Daclatasvir. 26 January 2016
Americas
The US Court of Appeals for the Federal Circuit has rejected Pfizer’s plea to extend the term of a patent centring on cancer treatment, upholding a lower court’s ruling that cleared the US Patent and Trademark Office of wrongdoing. 25 January 2016
Americas
Law firm Barnes & Thornburg has hired Scott Rothenberger and Jeffrey Stone as partners in the firm’s intellectual property department in Minneapolis. 22 January 2016
Americas
The US government has charged five Chinese scientists with conspiring to steal confidential research into anti-cancer drugs belonging to pharmaceutical company GSK. 22 January 2016
Americas
Law firm Hogan Lovells has hired Michael Dougherty and Tony Pezzano as partners in the firm’s intellectual property media and technology practice group in New York. 21 January 2016
Biotechnology
The European Patent Office has revoked Monsanto’s patent covering virus-resistant melons on technical grounds, following opposition to its registration by the Indian government and activist group No Patents on Seeds. 21 January 2016
Americas
Despite the current unfavourable climate, there is still reason to be optimistic about patenting diagnostic method claims in the US, particularly if the claim is focused on a particular disease, biomarker, and/or treatment and includes an active step that applies the diagnostic information, says Kevin O’Connor of Neal, Gerber & Eisenberg. 21 January 2016
Americas
The US Supreme Court has ordered a re-hearing of a spinal surgery patent dispute after it granted Medtronic’s grant, vacate, and remand (GVR) petition in its row with NuVasive. 20 January 2016
Americas
The US Court of Appeals for the Federal Circuit has ruled that the same three administrative patent law judges who determine whether to institute an inter partes review can also rule on the validity of the patent at issue. 19 January 2016